April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Comparison of Visual Field Severity Classification in Eyes With Glaucoma
Author Affiliations & Notes
  • M. Ng
    Hamilton Glaucoma Center, UC San Diego, La Jolla, California
  • L. Racette
    Hamilton Glaucoma Center, UC San Diego, La Jolla, California
  • J. P. Pascual
    Hamilton Glaucoma Center, UC San Diego, La Jolla, California
  • L. M. Zangwill
    Hamilton Glaucoma Center, UC San Diego, La Jolla, California
  • C. A. Girkin
    Ophthalmology, University of Alabama, Birmingham, Alabama
  • J. M. Liebmann
    Ophthalmology, New York Eye and Ear Infirmary, New York, New York
  • R. N. Weinreb
    Hamilton Glaucoma Center, UC San Diego, La Jolla, California
  • P. A. Sample
    Hamilton Glaucoma Center, UC San Diego, La Jolla, California
  • Footnotes
    Commercial Relationships  M. Ng, None; L. Racette, None; J.P. Pascual, None; L.M. Zangwill, Carl Zeiss Meditec, F; Heidelberg Engineering, F; C.A. Girkin, Carl Zeiss Meditec, F; Heidelberg Engineering, F; J.M. Liebmann, Carl Zeiss Meditec, R; Heidelberg Engineering, R; R.N. Weinreb, Carl Zeiss Meditec, F; Heidelberg Engineering, F; Carl Zeiss Meditec, C; P.A. Sample, Carl Zeiss Meditec, F; Welch-Allyn, F; Haag-Streit, F.
  • Footnotes
    Support  EY11008(LMZ); EY13959, Eyesight Foundation of AL(CAG); EY08208(PAS); EY14267(PAS,JL,CAG); Retention incentive grants in the form of cost-free medication: Alcon, Allergan, Pfizer, Merck, Santen, Incs.
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 5286. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. Ng, L. Racette, J. P. Pascual, L. M. Zangwill, C. A. Girkin, J. M. Liebmann, R. N. Weinreb, P. A. Sample; Comparison of Visual Field Severity Classification in Eyes With Glaucoma. Invest. Ophthalmol. Vis. Sci. 2009;50(13):5286.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To compare recently developed severity classification systems applied to a large number of Standard Automated Perimetry fields.

Methods: : The study included 2,085 eyes (49% OD) from 1,214 participants from the Diagnostic Innovations in Glaucoma Study (DIGS) and the African Descent and Evaluation Study (ADAGES). Fields were classified for severity using: (1) Advanced Glaucoma Intervention Study scoring system (AGIS), (2) Glaucoma Severity Staging system (GSS), and (3) Enhanced Glaucoma Severity Staging system (GSS-2). The following stages were compared: (s1) normal, (s2) mild/early/border, (s3) moderate, (s4) advanced/severe and (s5) end-stage. Mean defect (MD) and Visual Field Index (VFI) distributions across stages and classification systems were examined. Agreement in staging normal versus abnormal fields and severity staging across systems were assessed (Kappa statistic and matched-pair comparison).

Results: : Figure 1 shows the percentage of visual fields classified into each severity stage. Mean MD and VFI (±std) for fields staged as normal were: -0.4±1.3 and 99.4±0.7 for GSS; -0.6±1.2 and 98.9±1.3 for AGIS; -1.0±1.3 and 98.6±1.5 for GSS-2. Within GSS s4 and GSS-2 s3, two separate groups of MD and VFI scores were observed with peaks near -15/-5 and 56%/84% for GSS s4, and -7/-26 and 19%/80% for GSS2 s3. In staging normal versus abnormal fields, AGIS and GSS had moderate agreement (Κ=0.52±0.02); GSS and GSS-2 had fair agreement (Κ=0.36±0.02); AGIS and GSS-2 had moderate agreement (Κ=0.60±0.02). Visual fields tended to be staged with greatest severity using GSS and with least severity using AGIS (Wilcoxon sign-rank, p<0.05).

Conclusions: : Monitoring glaucoma severity enables better follow-up and a more reliable prognosis. When selecting a classification system and comparing severity of visual fields across studies that use different staging systems, care should be taken to account for their differences.

Keywords: visual fields • perimetry 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×